Aborode

Abdullahi Tunde Aborode MSc
Nationality	Nigeria
Occupation(s)	Scientist, Public Health Advocate
Academic background
Education	University of Ilorin (BSc) Mississippi State University (MSc)
Alma mater	University of Ilorin
Academic work
Institutions	Mississippi State University
Notable works	COVID-19

Abdullahi Tunde Aborode is a chemical biology scientist, public health researcher and global health advocate. He is the research director of Healthy Africans Platform, SWIS Research Africa, and MYBELLE.

Early life and education

Abdullahi Tunde Aborode was born in 1998 at Oyo town, Ibadan, Nigeria. He obtained his West African School Certificate from Anwarul Islam College with a focus in science and National Examination Council (NECO) in Anglican Methodist Secondary School at Oyo with a focus in Art. He obtained his first degree in Chemistry from University of Ilorin in 2019. In 2024, he completed his master's degree in Chemistry with a focus in Biochemistry from Mississippi State University, Starkville, USA.

Career

Academic career

Abdullahi Tunde Aborode started his research career during his undergraduate and have done numerous research in the field of chemical biology and public health with more than 100 papers published in top 25% in the world. He was ranked by SCIVAL as 1st author with most COVID-19 papers in Nigeria, and was ranked by SCOPUS as 71st author out of 500 top authors in Nigeria.

Memberships and fellowships

He is a member to American Association for the Advancement of Science, Citizen Science Association, American Scientific Affiliation, Yale Young African Scholars, United Nations on Chemical and Waste, American Chemical Society and International Chemical Biology Society. He won Madeleo Africa Fellowship, Policy for People Fellowship (Harvard University), UN YOUNGA, Research Hackthon (Harvard University, MIT University) and ReachSci fellowship by Cambridge University.

Selected publications

• Predictive identification and design of potent inhibitors targeting resistance-inducing candidate genes from E. coli whole genome sequences.
• Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling.
• Deep Learning and Structure-Based Virtual Screening for Drug Discovery against NEK7: A Novel Target for the Treatment of Cancer.
• Equal access of COVID-19 vaccine distribution in Africa: Challenges and way forward
• The Relevance of Bioinformatics Applications in the Discovery of Vaccine Candidates and Potential Drugs for COVID-19 Treatment.
• Impact of poor disease surveillance system on COVID-19 response in Africa: Time to rethink and rebuilt.